19 Dec 2011 07:54
PuriCore Receives Two Major Contracts
Approximately $7.8 Million in New and Existing Orders in Hand for New Year
MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 19 December 2011 -PuriCore (LSE: PURI), the water-based clean technology company, today announces receipt of major contracts across two businesses for installation in Q1 2012. In the US, a top-five supermarket retailer will add 200 FloraFresh Systems valued at $2.3 million. This order supplements the retailer's current installation base of approximately 140 FloraFresh Systems as a second PuriCore system in their stores. Combined with other customers'orders for Sterilox Fresh Systems, PuriCore expects to end 2011 with US orders for approximately 500 Systems valued at more than $6 million. These Systems will be installed in Q1 and Q2 2012. In addition, in the UK, PuriCore was awarded a £484,000 ($775,000) contract for the installation of eight ISIS automatic endoscopy washers in the OJEU tender proposal for the Greater Glasgow Health Board. This brings capital orders so far for the UK business in 2012 to $1.8 million.
Christopher Wightman, Executive Chairman, said:
"The expanded use of our FloraFresh Systems by this major supermarket retailer, in addition to the 1,700 stores in this chain already using a Sterilox Fresh System in their produce departments, illustrates the potential value of the new floral application of our technology just within our own customer base. The pace of installations of Sterilox Fresh Systems continues to grow as our technology becomes the de facto standard in the supermarket retail industry.
"We are also pleased to announce another contract win in Scotland following a competitive review process. This, along with contract wins earlier this year in Dumfries, Galloway and Fife, confirms the strong position of PuriCore's ISIS System in the endoscopy reprocessing market and reaffirms PuriCore as a market leader in Scotland."
Enquiries:
FTI Consulting PuriCore
Susan Quigley Chris Wightman
Ben Brewerton Executive Chairman
+44 (0) 20 7831 3113
About PuriCore
PuriCore plc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary green solutions that safely, effectively and naturally kill infectious pathogens without causing harm to human health or the environment. The Company's products are used in a broad range of markets that depend upon controlling contamination, including food retail and foodservice, medical device disinfection, and wound care. The Company's technologies are proven to be safe, environmentally friendly, and fast acting against a broad range of infectious pathogens, including major public health threats of C.difficile, E.coli, HIV, Human and Animal Influenza (including H1N1 and H5N1), Legionella, MRSA, M.tuberculosis, Norovirus, and Salmonella. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK.
To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.
Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions shareholders and prospective shareholders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.